Now that our models are up to speed, it’s going to be easier to update and present our ‘Junk in the Trunk’ series. And this time we’re back to Cronos, who released (in my opinion) a set of ra read more
Now that our models are up to speed, it’s going to be easier to update and present our ‘Junk in the Trunk read more
Well, several financial statements have been issues lately. And yep, TILT was one of them. Which, I had a scan through this morning and simply ‘noped’ right on past them. At this point (with rest read more
Well, several financial statements have been issues lately. And yep, TILT was one of them. Which, I had a sca read more
Ever since Cyto and I toured Cronos in January 2018 we have said “they are playing a different game”. This continues to be their game plan with the phrase “asset light” approach repeate read more
Ever since Cyto and I toured Cronos in January 2018 we have said “they are playing a different game”.&nbs read more
Open up the MDA and Fins and following along. I note that there is very little stratification of medical versus adult rec in the MDA. Which makes it hard to see if they are going backwards o read more
Open up the MDA and Fins and following along. I note that there is very little stratification of medical v read more
Nice to see the other analysts are catching on to the Finished Goods and throughput issues we have been talking about since mid-February. Cronos started the present Q with far lesser Finished read more
Nice to see the other analysts are catching on to the Finished Goods and throughput issues we have been talki read more